AstraZeneca’s RSV Antibody May Need More Data Due To Impact Of Maternal Vaccines

 
• By Derrick Gingery
maternal vaccine
Children may not need a nirsevimab dose as early as thought if maternal RSV vaccines are introduced. • Source: Shutterstock

More from Post-Marketing Regulation & Studies

More from Product Reviews